Fábio Cardoso Cruz

Fábio Cardoso Cruz

Auto-generated profile, based on publicly available information

Fábio Cardoso Cruz

Laboratory of Molecular and Behavioral Neuroscience, Departamento de Farmacologia Universidade Federal de São Paulo São Paulo Brazil

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2019 in Malaria Journal
Verified
Journal Article
Open access
PDF file
Guilherme SouzaGuilherme Souza
Guilherme Souza
RBRenata Bueno
Renata Bueno
JSJuliana Oliveira de Souza
Juliana Oliveira de Souza
CZCamila Lima Zanini
Camila Lima Zanini
FCFábio Cardoso Cruz
Fábio Cardoso Cruz
ACAnna Caroline
Anna Caroline
Background: Artemisinin-based combination therapy (ACT) is used as the first-line treatment of uncomplicated malaria caused by the Plasmodium falciparum parasite and chloroquine-resistant Plasmodium vivax parasites. Evidence of resistance to ACT has been reported in Cambodia, and without new and effective anti-malarial agents, malaria burden and mortality will rise. Methods: The used MolPrint 2D fingerprints and the Tanimoto similarity index were used to perform a structural similarity search within the Malaria Box collection to select diverse molecular scaffolds that are different from artesunate. Next, the inhibitory potency against the P. falciparum 3D7 strain (SYBR Green I inhibition assay) and the cytotoxicity against HepG2 cells (MTT and neutral red assays) were evaluated. Then, the speed of action, the combination profile of selected inhibitors with artesunate, and the P. berghei in vivo activity of the best compounds were assessed. Results: A set of 11 structurally diverse compounds from the Malaria Box with a similarity threshold of less than 0.05 was selected and compared with artesunate. The in vitro inhibitory activity of each compound confirmed the reported potencies (IC50 values ranging from 0.005 to 1 µM). The cytotoxicity of each selected compound was evaluated and used to calculate the selectivity index (SI values ranging from 15.1 to 6100). Next, both the speed of action and the combination profile of each compound with artesunate was assessed. Acridine, thiazolopyrimidine, quinoxaline, benzimidazole, thiophene, benzodiazepine, isoxazole and pyrimidoindole derivatives showed fast in vitro inhibitory activity of parasite growth, whereas hydrazinobenzimidazole, indenopyridazinone and naphthalenone derivatives were slow-acting in vitro inhibitors. Combinatory profile evaluation indicated that thiazolopyrimidinone and benzodiazepine derivatives have an additive profile, suggesting that the combination of these inhibitors with artesunate is favourable for in vitro inhibitory activity. The remaining compounds showed an antagonistic combinatory profile with artesunate. The collected data indicated that the indenopyridazinone derivative, a bc1 complex inhibitor, had a similar association profile in combination with proguanil when compared to atovaquone combined with proguanil, thereby corroborating the correlation between the molecular target and the combination profile. Lastly, the in vivo activity of the thiazolopyrimidinone and benzodiazepine derivatives were assessed. Both compounds showed oral efficacy at 50 mg/kg in a mouse model of Plasmodium berghei malaria (64% and 40% reduction in parasitaemia on day 5 post-infection, respectively). Conclusions: The findings in this paper shed light on the relationship among the speed of action, molecular target and combinatory profile and identified new hits with in vivo activity as candidates for anti-malarial combination therapy.

17 October 2017 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PPPaola Palombo
Paola Palombo
RLRodrigo M. Leao
Rodrigo M. Leao
PBPaula C. Bianchi
Paula C. Bianchi
POPaulo E. C. de Oliveira
Paulo E. C. de Oliveira
CPCleopatra da Silva Planeta
Cleopatra da Silva Planeta
FCFábio C. Cruz
Fábio C. Cruz
Evidence indicates that drug relapse in humans is often provoked by exposure to the self-administered drug-associated context. An animal model called “ABA renewal procedure” has been used to study the context-induced relapse to drug seeking. Here, we reported a new and feasible training procedure for the ABA renewal method to explore the role of the prelimbic cortex in context-induced relapse to ethanol seeking. By using a saccharin fading technique, we trained rats to self-administer ethanol (10%). The drug delivery was paired with a discrete tone-light cue. Lever pressing was subsequently extinguished in a non-drug-associated context in the presence of the discrete cue. Rats were subsequently tested for reinstatement in contexts A or B, under extinction conditions. Ethanol-associated context induced the reinstatement of ethanol seeking and increased the expression of Fos in the prelimbic cortex. The rate of neural activation in the prelimbic cortex was 3.4% in the extinction context B and 7.7% in the drug-associated context A, as evidenced by double-labeling of Fos and the neuron-specific protein NeuN. The reversible inactivation of the neural activity in the prelimbic cortex with gamma-Aminobutyric acid (GABA) receptor agonists (muscimol + baclofen) attenuated the context-induced reinstatement of ethanol self-administration. These results demonstrated that the neuronal activation of the prelimbic cortex is involved in the context-induced reinstatement of ethanol seeking.

1 February 2021 in Behavioural Brain Research
Verified
Journal Article
Closed access
JFJaqueline Moreira Felipe
Jaqueline Moreira Felipe
PPPaola Palombo
Paola Palombo
PBPaula Cristina Bianchi
Paula Cristina Bianchi
CZCaroline Riberti Zaniboni
Caroline Riberti Zaniboni
AAAugusto Anésio
Augusto Anésio
FCFábio Cardoso Cruz
Fábio Cardoso Cruz

24 November 2023 in Alcohol, Clinical and Experimental Research
Verified
Journal Article
Closed access
NBNatalia B. Bertagna
Natalia B. Bertagna
LWLisa Wilson
Lisa Wilson
CBConnor K. Bailey
Connor K. Bailey
FCFabio C. Cruz
Fabio C. Cruz
LALucas Albrechet‐Souza
Lucas Albrechet‐Souza
TWTiffany A. Wills
Tiffany A. Wills

1 February 2021 in Neuroscience Letters
Verified
Journal Article
Closed access
PPPaola Palombo
Paola Palombo
SESheila Antonagi Engi
Sheila Antonagi Engi
TYThais Suemi Yokoyama
Thais Suemi Yokoyama
ABAndréia Gomes Bezerra
Andréia Gomes Bezerra
DCDaniela Fernández Curado
Daniela Fernández Curado
JGJosé Carlos F. Galduróz
José Carlos F. Galduróz

18 March 2025 in Biological Psychiatry
Verified
Journal Article
Open access
RMRaphaële Mongrédien
Raphaële Mongrédien
AAAugusto Anesio
Augusto Anesio
GFGustavo J.D. Fernandes
Gustavo J.D. Fernandes
AEAndrew L. Eagle
Andrew L. Eagle
SMSteeve Maldera
Steeve Maldera
VVVincent Vialou
Vincent Vialou
Astrocytes in the nucleus accumbens (NAc) play a dynamic role in regulating synaptic plasticity induced by drugs of abuse through modulation of glutamatergic neurotransmission. Astrocyte-secreted factors may also contribute to the reprogramming of brain circuitry that leads to drug-seeking behavior. Here, we investigated the role of astrocyte Ca2+ signals in vivo and of the astrocyte-secreted protein hevin in the rewarding properties of cocaine. Ca2+ signals in NAc astrocytes were measured by in vivo fiber photometry during conditioned place preference (CPP) to cocaine. Depletion of Ca2+ and chemogenetic activation were used to evaluate the contribution of astrocyte Ca2+ signals to cocaine CPP. The effects of cocaine in hevin-null mice and after hevin knockdown in NAc astrocytes were evaluated by imaging of medium spiny neuron spines, electrophysiology, and CPP. Hevin secretion was monitored by light-sheet imaging in brain slices. Cocaine increased the amplitude of Ca2+ signals in astrocytes during conditioning. Attenuating Ca2+ signals in astrocytes prevented cocaine CPP, whereas augmenting these signals potentiated this conditioning. Astrocyte activation induced a surge in hevin secretion ex vivo. Hevin knockdown in NAc astrocytes led to a decrease in CPP and in structural and synaptic plasticity induced by cocaine in medium spiny neurons. These findings reveal a fine-tuning by cocaine of in vivo Ca2+ signals in NAc astrocytes. Astrocyte Ca2+ signals are sufficient and necessary for the acquisition of cocaine-seeking behavior. Hevin can be released upon astrocyte activation and is a major effector of the action of cocaine and Ca2+ signals on reward and neuronal plasticity.